Deutsch English Français

Contact

EP3809136

European procedure

Quick help

Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...

News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...

Extract from the Register of European Patents

EP About this file: EP3809136

EP3809136 - TCR-INDEPENDENT MOLECULAR IDENTIFICATION OF MUTATION-RELATED AND TUMOR-SPECIFIC T CELLS [Right-click to bookmark this link]
Status	The application is deemed to be withdrawn Status updated on 25.02.2022 Database last updated on 14.09.2024
Former	The application has been published Status updated on 19.03.2021
Most recent event Tooltip	25.02.2022	Application deemed to be withdrawn	published on 30.03.2022 [2022/13]
Applicant(s)	For all designated states Medizinische Hochschule Hannover Carl-Neuberg-Strasse 1 30625 Hannover / DE
	[2021/16]
Inventor(s)	01 / Woller, Norman Gerhart-Hauptmann-Str. 22 30629 Hannover / DE
	[2021/16]
Representative(s)	Moré, Solveig Helga, et al Kroher Strobel Rechts- und Patentanwälte PartmbB Bavariaring 20 80336 München / DE
	[2021/16]
Application number, filing date	19203651.5	16.10.2019
	[2021/16]
Filing language	EN
Procedural language	EN
Publication	Type:	A1 Application with search report
	No.:	EP3809136
	Date:	21.04.2021
	Language:	EN
	[2021/16]
Search report(s)	(Supplementary) European search report - dispatched on:	EP	15.04.2020
Classification	IPC:	G01N33/569, G01N33/574	[2021/16]
	CPC:	G01N33/56972 (EP); G01N33/56966 (US); G01N33/574 (EP); G01N33/57492 (EP,US); G01N2333/70517 (EP,US); G01N2333/70553 (EP,US); (+) G01N2333/70596 (EP); G01N2800/52 (EP) (-)
Designated contracting states	AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR [2021/16]
Extension states	BA	Not yet paid
	ME	Not yet paid
Validation states	KH	Not yet paid
	MA	Not yet paid
	MD	Not yet paid
	TN	Not yet paid
Title	German:	TCR-UNABHÄNGIGE MOLEKULARE IDENTIFIZIERUNG VON MUTATIONSBEZOGENEN UND TUMORSPEZIFISCHEN T-ZELLEN	[2021/16]
	English:	TCR-INDEPENDENT MOLECULAR IDENTIFICATION OF MUTATION-RELATED AND TUMOR-SPECIFIC T CELLS	[2021/16]
	French:	IDENTIFICATION MOLÉCULAIRE DE CELLULES T LIÉES À LA MUTATION ET SPÉCIFIQUES DE TUMEUR INDÉPENDANTE DU TCR	[2021/16]
Examination procedure	22.10.2021	Application deemed to be withdrawn, date of legal effect [2022/13]
	12.11.2021	Despatch of communication that the application is deemed to be withdrawn, reason: examination fee not paid in time [2022/13]
Fees paid	Penalty fee
	Additional fee for renewal fee
	31.10.2021	03 M06 Not yet paid
Opt-out from the exclusive Tooltip competence of the Unified Patent Court	See the Register of the Unified Patent Court for opt-out data
	Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Documents cited:	Search	[A]WO2013126809 (SLOAN KETTERING INST CANCER [US]) [A] 1-16 * the whole document * * abstract *;
		[A]WO2019014581 (BROAD INST INC [US], et al) [A] 1-16 * the whole document * * abstract * * claims 1,14,50 *;
		[A]WO2019053244 (UNIV ZUERICH [CH]) [A] 1-16 * the whole document * * abstract *;
		[A] - SOLINAS CINZIA ET AL, "The immune infiltrate in prostate, bladder and testicular tumors: An old friend for new challenges", CANCER TREATMENT REVIEWS, ELSEVIER, AMSTERDAM, NL, (20161230), vol. 53, doi:10.1016/J.CTRV.2016.12.004, ISSN 0305-7372, pages 138 - 145, XP029903744 [A] 1-16 * the whole document * * abstract * * tables 1-3 * DOI: http://dx.doi.org/10.1016/j.ctrv.2016.12.004
		[A] - PATRICK A OTT ET AL, "An Update on Adoptive T-Cell Therapy and Neoantigen Vaccines", AMERICAN SOCIETY OF CLINICAL ONCOLOGY EDUCATIONAL BOOK. AMERICAN SOCIETY OF CLINICAL ONCOLOGY. MEETINGUNITED STATES2013, (20190517), vol. 39, doi:10.1200/EDBK_, ISSN 1548-8756, pages e70 - e78, XP055682464 [A] 1-16 * the whole document * * abstract * * Box: Practical applications * * section "Targeting neoantigens with adoptive transfer of TILs" on pages e71-e72 * * section "Endogenous T-cell therapy" on page e74 * DOI: http://dx.doi.org/10.1200/EDBK_
	by applicant	- OSTROUMOV et al., Cell. Mol. Life Sci., (20180000), vol. 75, pages 689 - 713
		- DUNN et al., Annu Rev Immunol, (20040000), vol. 22, pages 329 - 360
		- DUDLEY et al., Science, (20020000), vol. 298, pages 850 - 854
		- KNOCKE et al., Cell Reports, (20160000), vol. 17, pages 2234 - 2246
		- RAY et al., J. Immunol., (20090000), vol. 183, pages 7672 - 82
		- CASTLE et al., Cancer Res, (20120000), vol. 72, pages 1081 - 1091
		- VAN ROOIJ et al., J Clin Oncol, (20130000), vol. 31, pages e439 - e442
		- GARCIA-GUERRERO et al., Front. Immunol., (20180000), vol. 9, pages 1971 - 1986
		- HUANG et al., Nature, (20170000), vol. 545, pages 60 - 65
		- LEBEL-BINAY et al., J Immunol., (19950000), vol. 155, pages 101 - 110
		- TSAI et al., FEBS Lett., (20110000), vol. 585, no. 20, pages 3166 - 3173
		- GUBIN et al., Nature, (20140000), vol. 515, no. 7528, pages 577 - 581
		- CHAMPIAT et al., Clin Cancer Res, (20160000), vol. 23, no. 8, pages 1920 - 8
		- KNOCKE et al., Cell Rep, (20160000), vol. 17, pages 2234 - 46
		- WOLLER et al., J Clin Invest., (20110000), vol. 121, no. 7, pages 2570 - 2582
		- KHALAF et al., Clinical Gastroenterology and Hepatology, (20170000), vol. 15, pages 273 - 2
		- CHEN et al., Oncology Letters, (20180000), vol. 15, pages 855 - 862
		- ROVARIS et al., Blood, (20060000), vol. 108, no. 9, pages 2897 - 905

The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.

Legal notice
Terms of use
24.2.25; 34p